4.8 Article

An Integrated Polymeric mRNA Vaccine without Inflammation Side Effects for Cellular Immunity Mediated Cancer Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Green Stereoregular Polymerization of Poly(methyl methacrylate)s Through Vesicular Catalysis

Beike Cai et al.

Summary: This paper reports for the first time on a vesicular catalysis method for the green stereoregular polymerization of isotactic-rich PMMA in water and at ambient temperature and pressure. The isotactic degree of the as-prepared PMMAs increases with the decrease of vesicle size, and this work represents a new application of polymer vesicles in stereoregular polymerization.

CCS CHEMISTRY (2022)

Review Chemistry, Multidisciplinary

Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines

Jing Liu et al.

Summary: Cancer vaccines aim to stimulate tumor-specific immune responses while sparing normal tissues, with bioinspired materials and technologies playing a role in reshaping the field of cancer nanomedicine. By mimicking desirable properties in nature, bioinspired engineering of cancer vaccine delivery platforms can enhance therapeutic efficacy and safety profiles for clinical translation.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)

Hamideh Parhiz et al.

Summary: This study investigates the effects of nucleoside-modified RNA lipid nanoparticles (modmRNA-LNPs) on inflammation and immune response in mice. The results show that modmRNA-LNPs enhance inflammatory cytokine responses after lipopolysaccharide (LPS) immune stimulation, and macrophages play a key role in mediating this phenomenon. Additionally, pretreatment with anti-inflammatory drugs can partially alleviate the inflammatory response.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Rapid Surface Display of mRNA Antigens by Bacteria-Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine

Yao Li et al.

Summary: This study utilized bacteria-derived outer membrane vesicles (OMVs) as a delivery platform for mRNA, genetically modified to deliver specific mRNA antigens into dendritic cells, triggering anti-tumor immune responses. The results showed that this platform significantly inhibited tumor progression and achieved 37.5% complete regression in an in vivo model.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Engineered Nanoerythrocytes Alleviate Central Nervous System Inflammation by Regulating the Polarization of Inflammatory Microglia

Na Yin et al.

Summary: Reprogramming microglia from classical M1 to alternative M2 through induction of HO-1, Notch1/Hes1/Stat3 signaling, and inhibition of NF-kappa B p65 translocation provides a promising therapeutic strategy for central nervous system disorders.

ADVANCED MATERIALS (2022)

Article Immunology

Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model

Can Li et al.

Summary: Inadvertent intravenous injection of COVID-19 mRNA vaccines may induce myopericarditis in mice. Withdrawal of syringe plunger to exclude blood aspiration may reduce this risk.

CLINICAL INFECTIOUS DISEASES (2022)

Article Chemistry, Multidisciplinary

The Unexpected Importance of the Primary Structure of theHydrophobic Part of One-Component Ionizable Amphiphilic JanusDendrimers in Targeted mRNA Delivery Activity

Dapeng Zhang et al.

Summary: Viral and synthetic vectors have significantly impacted genetic nanomedicine, particularly in the rapid development of Covid-19 vaccines. Synthetic vectors have unlimited synthetic capability and exhibit active delivery effects. Studies targeting different organs have shown that by designing the hydrophobic region, IAJDs have increased the activity of gene delivery.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Review Biotechnology & Applied Microbiology

The clinical progress of mRNA vaccines and immunotherapies

Ann J. Barbier et al.

Summary: The emergency use authorizations (EUAs) of mRNA-based vaccines against SARS-CoV-2 highlight the transformative potential of this nucleic acid technology. Clinical applications of mRNA have mainly focused on vaccines for infectious diseases and cancer, but there are challenges in using mRNA for immunotherapies. The past year has seen significant progress in the clinical development of mRNA therapies for COVID-19, as well as other diseases such as influenza, HIV, and cancer.

NATURE BIOTECHNOLOGY (2022)

Article Immunology

IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

Siri Tahtinen et al.

Summary: Lipid-formulated RNA vaccines can cause systemic inflammatory responses in humans, which were not predicted in preclinical studies. The IL-1 pathway plays a key role in triggering vaccine-induced inflammation, but this effect is dampened in mice.

NATURE IMMUNOLOGY (2022)

Article Engineering, Biomedical

Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria

Yale Yue et al.

Summary: Outer membrane vesicles (OMVs) produced in the intestine by ingested genetically engineered bacteria, which are fused with tumour antigens, can serve as effective oral tumour vaccines in mice. These OMVs can stimulate dendritic cell maturation, inhibit tumour growth, and generate long-term antitumour immunity.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Chemistry, Multidisciplinary

Herpesvirus-Mimicking DNAzyme-Loaded Nanoparticles as a Mitochondrial DNA Stress Inducer to Activate Innate Immunity for Tumor Therapy

Xiu Zhao et al.

Summary: By mimicking the structure and infection processes of herpesvirus, a herpesvirus-mimicking nanoparticle named Vir-ZM@TD has been engineered for effective tumor therapy, showing promising results in inducing innate immunity and enhancing the survival time of tumor-bearing mice.

ADVANCED MATERIALS (2022)

Review Chemistry, Multidisciplinary

Extracellular-Vesicle-Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer-Immunity Cycle

Tuying Yong et al.

Summary: Immunotherapy against tumors has made progress but remains limited. Extracellular vesicle-based drug delivery systems can enhance immune responses by activating multiple steps of the cancer-immunity cycle.

ADVANCED MATERIALS (2022)

Article Cell Biology

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

Chengqiong Mao et al.

Summary: The study aimed to develop an approach to facilitate cancer therapy-induced immunogenic cell death and limit adenosine production. The researchers constructed ROS-producing nanoparticles to carry an ectonucleotidase inhibitor and demonstrated that the approach enhanced anticancer immunity and tumor regression in mouse models. The combination with anti-PD1 immunotherapy also showed promising results. The approach also induced immunological effects in patient-derived organotypic tumor spheroid model, suggesting its potential for treating human cancers.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Review Medicine, Research & Experimental

Advances in the polymeric delivery of nucleic acid vaccines

Gang Chen et al.

Summary: Nucleic acid vaccines, especially mRNA vaccines, have unique advantages in the COVID-19 pandemic. The use of polymeric materials as delivery carriers has greatly improved the development of nucleic acid vaccines for prevention and treatment. This review summarizes the different polymers and formulations used for nucleic acid vaccine delivery and discusses existing problems, coping strategies, and future prospects.

THERANOSTICS (2022)

Review Chemistry, Multidisciplinary

Emerging mRNA technologies: delivery strategies and biomedical applications

Yufen Xiao et al.

Summary: This article provides an overview of the significant advancements in emerging mRNA technologies, along with the accompanying chemical designs and principles. Various nanoparticle delivery strategies are discussed, and typical mRNA delivery platforms for various biomedical applications are highlighted. The article also offers insights into the challenges and future development of clinical translation for these mRNA technologies.

CHEMICAL SOCIETY REVIEWS (2022)

Article Chemistry, Physical

A DNA nanodevice-based vaccine for cancer immunotherapy

Shaoli Liu et al.

Summary: A DNA nanodevice vaccine has been developed to stimulate a tumor-specific cytotoxic T lymphocyte response, leading to inhibition of tumor growth and prevention of metastasis. The vaccine utilizes molecular adjuvants and antigen peptides within a tubular DNA nanostructure to trigger T-cell activation and cancer cytotoxicity, showing promising results in mouse cancer models. The vaccination generates long-term T-cell responses which effectively protect against tumor rechallenge.

NATURE MATERIALS (2021)

Review Chemistry, Multidisciplinary

Recent Advances in the Noninvasive Delivery of mRNA

Ming Qin et al.

Summary: Research on mRNA-based therapies has flourished in the past two decades due to the advantages of mRNA. Various noninvasive delivery strategies have been developed to overcome intracellular barriers, with nasal and pulmonary delivery being the most studied areas. The advancement in noninvasive mRNA delivery is expected to accelerate the translation from experimental research to clinical applications.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

Review Chemistry, Multidisciplinary

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing

Min Qiu et al.

Summary: mRNA technology has garnered significant attention for its potential in revolutionizing medicine, particularly in areas such as vaccination and cancer immunotherapy. Advances in synthetic lipid nanoparticles (LNPs) as delivery systems have shown promise in facilitating mRNA-based therapies.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

Article Chemistry, Multidisciplinary

Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles

Uri Elia et al.

Summary: This study presents the design of an mRNA vaccine based on lipid nanoparticles (LNPs) encapsulated SARS-CoV-2 human Fc-conjugated receptor-binding domain (RBD-hFc), demonstrating its potential to induce strong immune responses and produce neutralizing antibodies, making it a promising candidate for a COVID-19 vaccine.

ACS NANO (2021)

Article Chemistry, Multidisciplinary

Self-assembled polymeric micelle as a novel mRNA delivery carrier

Jin Ren et al.

Summary: A novel self-assembled polymeric micelle based on vitamin E succinate modified polyethyleneimine copolymer (PVES) was designed for mRNA delivery. In vitro experiments showed high transfection efficiencies and low cytotoxicity of PVES compared to PEI 25k. Mice administered intramuscularly with PVES/SARS-CoV-2 mRNA vaccine induced potent antibody response and showed no obvious toxicity.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Multidisciplinary Sciences

Ionizable lipid nanoparticles for in utero mRNA delivery

Rachel S. Riley et al.

Summary: Using ionizable lipid nanoparticles, mRNA can be effectively and safely delivered to mouse fetuses to produce therapeutic secreted proteins, providing a platform for prenatal gene editing and protein replacement.

SCIENCE ADVANCES (2021)

Article Chemistry, Multidisciplinary

Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes

Shuai Liu et al.

Summary: The study introduces a rational design and combinatorial synthesis of zwitterionic phospholipidated polymers (ZPPs) for efficient mRNA delivery to spleen and lymph nodes, with potential for substantial immunotherapeutic applications.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Chemistry, Multidisciplinary

Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers

Dapeng Zhang et al.

Summary: Efficient delivery of nucleic acids is crucial in genetic nanomedicine, and lipid nanoparticles as well as Janus dendrimers have shown great success in delivering mRNA for Covid-19 vaccines. By modifying the structure, targeted delivery of mRNA using Janus dendrimers can be switched from lung to liver and spleen, expanding the utility of dendrimersome nanoparticles from therapeutics to vaccines.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

Article Chemistry, Multidisciplinary

In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy

Yue Yin et al.

Summary: The research team developed a transformable hydrogel that can generate nanovaccines for up to 30 days after injection, showing promising potential for effective cancer immunotherapy.

NANO LETTERS (2021)

Article Chemistry, Physical

Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing

Shuai Liu et al.

Summary: The study successfully delivered mRNA or single-guide RNA for gene editing in vivo using combinatorially synthesized ionizable phospholipids. Optimized iPhos lipids can change shapes in endosomal acidic environments to facilitate the release of gene editing materials. When working synergistically with helper lipids, iPhos lipids can achieve targeted delivery to specific organs.

NATURE MATERIALS (2021)

Article Multidisciplinary Sciences

Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling

Hongxia Zhang et al.

Summary: The C1 lipid nanoparticle-based mRNA cancer nanovaccine efficiently delivers mRNA to antigen presenting cells, activates TLR4, induces inflammatory cytokines in dendritic cells, and shows significant antitumor efficacy.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

Sonia Ndeupen et al.

Summary: Vaccines based on mRNA-containing LNPs are a promising platform for COVID-19 vaccines, but may lead to highly inflammatory responses. Studies have shown that LNPs can induce massive neutrophil infiltration and activation of various inflammatory pathways in mice, which may be one of the factors affecting their immunogenicity and side effects.

ISCIENCE (2021)

Article Materials Science, Biomaterials

Magnetoferritin enhances T2 contrast in magnetic resonance imaging of macrophages

Ambrish Kumar et al.

Summary: The study utilized archaeal magnetoferritin for MR imaging of macrophages and found significantly higher contrast compared to standard ferritin. The magnetoferritin, synthesized by loading iron under anaerobic conditions, displayed a stable core structure with enhanced activity.

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Review Biotechnology & Applied Microbiology

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Namit Chaudhary et al.

Summary: mRNA vaccines have been established as a rapid, effective, and safe approach for protecting individuals from infectious diseases, especially during the COVID-19 pandemic. Further research is needed to optimize mRNA vaccine design, delivery, and applications for a range of infectious diseases.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Cell Biology

Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models

Yao-Xin Lin et al.

Summary: Clinical evidence suggests that restoration of functional PTEN through mRNA delivery by polymeric nanoparticles can effectively induce immune activation in tumor cells, reversing immunosuppressive tumor microenvironment and enhancing sensitivity to immune checkpoint blockade therapy. In vivo results show that PTEN mRNA nanoparticles promote CD8(+) T cell infiltration, increase proinflammatory cytokine expression, and decrease regulatory T cells and myeloid-derived suppressor cells, resulting in potent antitumor effects and immunological memory in cancer models.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Nanoscience & Nanotechnology

Lipid nanoparticles for mRNA delivery

Xucheng Hou et al.

Summary: Lipid nanoparticle-mRNA formulations have successfully entered clinical use as COVID-19 vaccines, representing a major milestone in mRNA therapeutics. This review discusses the design of lipid nanoparticles for mRNA delivery, emphasizing key points for clinical translation and preclinical studies of lipid nanoparticle-mRNA therapeutics for various diseases.

NATURE REVIEWS MATERIALS (2021)

Article Medicine, Research & Experimental

Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment

Te Bu et al.

Summary: A nano-system has been developed to deliver inflammation-responsive Il-10 mRNA preferentially into macrophages for tailored inflammation control, showing promising potential for treating inflammatory diseases like atherosclerosis.

THERANOSTICS (2021)

Article Pharmacology & Pharmacy

Virus-Mimic mRNA Vaccine for Cancer Treatment

Chaoyang Meng et al.

Summary: The study introduces a mRNA virus-mimicking vaccine platform that effectively stimulates dendritic cells for anti-tumor immunity. The inclusion of CpG oligonucleotide is essential for vaccine activity and also serves as a potent adjuvant and a checkpoint blockade agent.

ADVANCED THERAPEUTICS (2021)

Review Chemistry, Multidisciplinary

ROS Scavenging Biopolymers for Anti-Inflammatory Diseases: Classification and Formulation

Jianhua Zhang et al.

ADVANCED MATERIALS INTERFACES (2020)

Article Multidisciplinary Sciences

An implantable blood clot-based immune niche for enhanced cancer vaccination

Qin Fan et al.

SCIENCE ADVANCES (2020)

Article Nanoscience & Nanotechnology

Porphyrin Alternating Copolymer Vesicles for Photothermal Drug-Resistant Bacterial Ablation and Wound Disinfection

Chuanshuang Chen et al.

ACS APPLIED BIO MATERIALS (2020)

Article Multidisciplinary Sciences

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Daniel Rosenblum et al.

SCIENCE ADVANCES (2020)

Review Biotechnology & Applied Microbiology

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Piotr S. Kowalski et al.

MOLECULAR THERAPY (2019)

Review Medicine, Research & Experimental

STING activation in cancer immunotherapy

Ting Su et al.

THERANOSTICS (2019)

Article Engineering, Biomedical

mRNA Delivery System for Targeting Antigen-Presenting Cells In Vivo

Cristina Fornaguera et al.

ADVANCED HEALTHCARE MATERIALS (2018)

Article Materials Science, Biomaterials

Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine

Ya-Nan Fan et al.

BIOMATERIALS SCIENCE (2018)

Review Immunology

Cross-presentation by dendritic cells

Olivier P. Joffre et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Article Biochemical Research Methods

Lymph node mapping in the mouse

Maria I. Harrell et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2008)